Loading...

PR Information Data

AdipoLABs CEO Han Sung-ho was appointed as an advisory member of the Future Strategy Special Committee of the Constitutional Council.
24-03-14 16:39 877회 0건

AdipoLABs CEO Han Sung-ho was appointed as an advisory member of the Future Strategy Special Committee of the Constitutional Council.



 

[Medical Newspaper/Daily Newspaper = Reporter Oh In-gyu] AdipoLABs announced that CEO Han Sung-ho was appointed as an advisory member of the Ministry of Health and Welfare of the Future Strategy Special Committee in the National Assembly constitutional meeting room on the 23rd.

 

The Korean Constitutional Association (Chairman Kim Il-yoon) is an incorporated association that was founded in 1968 as the National Assembly Member's Association for the purpose of maintaining friendship among former members of the National Assembly and maintaining democratic constitution, and changed to its current name in 1989.



3731654643_1661389034.1564.png

Han Sung-ho, CEO of AdipoLABs, receiving a letter of appointment from Chairman Lee Hee-gyu of the Future Strategy Special Committee of the Constitutional Council of the Republic of Korea.


It is known that the appointment of advisory members was made by the Future Strategy Special Committee under the Constitutional Council, which selected the right people to play an advisory role from all levels of society for the development of Korea's medical care and health and welfare sectors.

 

With this appointment, CEO Han was recognized for his significant contribution to the medical industry through a systematic networking by supporting the International Virus Research Alliance (IVRA), which has a growing reputation as a collaborative organization that effectively aims to heal COVID-19. Han and his employees’ hard work of having manufactured the medical high-frequency device 'REMISSION 1℃' for over 10 years was recognized through this appointment as well. REMISSION 1℃ received permission from the Ministry of Food and Drug Safety for cancer treatment in 2015, and since then, it has been successful in treating patients at both domestic and foreign medical institutions for various cancers.

 

On this day, CEO Han Sung-ho expressed his ambition, saying, “I want to faithfully fulfill my role as an advisory committee member for the future development of Korea.”

 

 

출처 : 의학신문(http://www.bosa.co.kr)

 

 

link : http://www.bosa.co.kr/news/articleView.html?idxno=2179729